Computational analysis of eugenol inhibitory activity in lipoxygenase and cyclooxygenase pathways.
Ontology highlight
ABSTRACT: Chronic inflammation is triggered by numerous diseases such as osteoarthritis, Crohn's disease and cancer. The control of the pro-inflammatory process can prevent, mitigate and/or inhibit the evolution of these diseases. Therefore, anti-inflammatory drugs have been studied as possible compounds to act in these diseases. This paper proposes a computational analysis of eugenol in relation to aspirin and diclofenac and analyzing the ADMET profile and interactions with COX-2 and 5-LOX enzymes, important enzymes in the signaling pathway of pro-inflammatory processes. Through the analysis of ADMET in silico, it was found that the pharmacokinetic results of eugenol are similar to NSAIDs, such as diclofenac and aspirin. Bioinformatics analysis using coupling tests showed that eugenol can bind to C
SUBMITTER: das Chagas Pereira de Andrade F
PROVIDER: S-EPMC7530671 | biostudies-literature | 2020 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA